LRRC61: A Potential Drug Target Or Biomarker for Multiple Diseases

Target Name: LRRC61

NCBI ID: G65999

LRRC61

LRRC61: A Potential Drug Target Or Biomarker for Multiple Diseases

LRRC61 (FLJ31392) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the long non-coding RNA (lncRNA) family, which are a class of RNA molecules that are larger than most proteins and can interact with other proteins to regulate gene expression.

LRRC61 has been shown to play a role in several cellular processes, including cell signaling, DNA replication, and repair, as well as inflammation and stress responses. It is also involved in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Recent studies have suggested that LRRC61 may be a drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One potential mechanism by which LRRC61 may be targeted by drugs is through its role in cell signaling. LRRC61 has been shown to play a role in several signaling pathways, including the TGF-β pathway, which is involved in cell growth, differentiation, and stress responses. Many drugs that are used to treat these diseases work by inhibiting the activity of these signaling pathways. LRRC61 may be a good target for these drugs because it is involved in the regulation of these processes and is a protein that is expressed in multiple tissues, which makes it difficult to target with small molecules.

Another potential mechanism by which LRRC61 may be targeted by drugs is through its role in DNA replication and repair. LRRC61 is involved in the regulation of DNA replication and repair, which is important for the development and maintenance of a healthy genome. Many drugs that are used to treat cancer work by inhibiting the activity of DNA replication and repair pathways. LRRC61 may be a good target for these drugs because it is involved in the regulation of these processes and is a protein that is expressed in multiple tissues, which makes it difficult to target with small molecules.

In addition to its role in cell signaling and DNA replication and repair, LRRC61 may also be a good biomarker for some diseases. For example, LRRC61 has been shown to be expressed in the brains of individuals with Alzheimer's disease, which is a neurodegenerative disorder. This suggests that LRRC61 may be a good biomarker for this disease. Additionally, LRRC61 has been shown to be involved in the regulation of inflammation and stress responses, which are important for the development and progression of autoimmune disorders. This suggests that LRRC61 may be a good biomarker for autoimmune disorders.

Overall, LRRC61 is a protein that is involved in several cellular processes that are important for the development and maintenance of health. It is possible that LRRC61 may be a drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of LRRC61 in these processes and to develop effective treatments.

Protein Name: Leucine Rich Repeat Containing 61

The "LRRC61 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LRRC61 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets